It would be interesting to see a breakdown of who pays for what in the development of a needed drug. For instance, how big are the tax credits for R&D? How muc

It would be interesting to see a breakdown of who pays for what in the development of a needed drug. For instance, how big are the tax credits for R&D? How much of the testing is subsidised or outright paid for by taxpayers? And of course: what proportion of drug development is to replace high earning drugs for which the patent protection is expiring. (ie "solved problems"). I am not convinced that the drug industry needs patent protection. I have a gnawing suspicion that we have reached a point where it might be a better idea to just remove patents and see where the chips fall.